Infinity Pharmaceuticals Inc Share Price Today: Live Updates & Key Insights

Infinity Pharmaceuticals Inc share price today is $null, up null%. The stock opened at $null against the previous close of $null, with an intraday high of $null and low of $null.

Infinity Pharmaceuticals Inc Share Price Chart

Infinity Pharmaceuticals Inc

us-stock
To Invest in {{usstockname}}
us-stock

Infinity Pharmaceuticals Inc Share Price Performance

$null null(null%) null at 23 Mar 2026 01:39 PM Biotechnology
Lowest Today 0.00
Highest Today 0.00
Today’s Open 0.00
Prev. Close 0.00
52 Week High 0.00
52 Week Low 0.00
Day’s Range: Low null High null
52-Week Range: Low 0.00 High 0.00
1 day return -
1 Week return -
1 month return -
3 month return -
6 month return -
1 year return -
3 year return -
5 year return -
10 year return -

Infinity Pharmaceuticals Inc Institutional Holdings

Infinity Pharmaceuticals Inc Market Status

Infinity Pharmaceuticals Inc Fundamentals

Market Cap 0.00 M

PB Ratio 8.0285

PE Ratio 0.0

Enterprise Value -17.11 M

Total Assets 42.15 M

Volume null

Infinity Pharmaceuticals Inc Company Financials

About Infinity Pharmaceuticals Inc & investment objective

Company Information Infinity Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel medicines for people with cancer. The company's product candidate, including eganelisib (IPI-549), an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of metastatic triple negative breast cancer and urothelial cancer; and Phase 1/1b clinical trials for the treatment of solid tumors. Infinity Pharmaceuticals, Inc. has strategic alliances with Intellikine, Inc. to discover, develop, and commercialize pharmaceutical products targeting the delta and/or gamma isoforms of PI3K; Verastem, Inc. to research, develop, commercialize, and manufacture duvelisib and products containing duvelisib; and PellePharm, Inc. to develop and commercialize rights to its hedgehog inhibitor program, IPI-926, a clinical-stage product candidate, as well as collaboration agreements with F. Hoffmann-La Roche Ltd., and Bristol Myers Squibb Company. Infinity Pharmaceuticals, Inc. was founded in 1995 and is headquartered in Cambridge, Massachusetts. On September 29, 2023, Infinity Pharmaceuticals, Inc. along with its affiliate, a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. The plan was later approved as Chapter 11 liquidation on March 7, 2024.

Organisation Biotechnology

Employees 30

Industry Biotechnology

CEO null

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Infinity Pharmaceuticals Inc FAQs

What is the share price of Infinity Pharmaceuticals Inc today?

The current share price of Infinity Pharmaceuticals Inc is $null.

Can I buy Infinity Pharmaceuticals Inc shares in India?

Yes, Indian investors can buy Infinity Pharmaceuticals Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Infinity Pharmaceuticals Inc shares in India?

You can easily invest in Infinity Pharmaceuticals Inc shares from India by:

Can I buy fractional shares of Infinity Pharmaceuticals Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Infinity Pharmaceuticals Inc?

Infinity Pharmaceuticals Inc has a market cap of $0.00 M.

In which sector does Infinity Pharmaceuticals Inc belong?

Infinity Pharmaceuticals Inc operates in the Biotechnology sector.

What documents are required to invest in Infinity Pharmaceuticals Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Infinity Pharmaceuticals Inc?

The PE ratio of Infinity Pharmaceuticals Inc is N/A and the PB ratio is 8.03.